Intuitive Surgical (NASDAQ:ISRG – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.
Valuation and Earnings
This table compares Intuitive Surgical and Stryker”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intuitive Surgical | $10.06 billion | 13.74 | $2.86 billion | $8.27 | 48.25 |
| Stryker | $25.12 billion | 4.70 | $3.25 billion | $9.39 | 33.00 |
Stryker has higher revenue and earnings than Intuitive Surgical. Stryker is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Intuitive Surgical has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, Stryker has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.
Profitability
This table compares Intuitive Surgical and Stryker’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intuitive Surgical | 25.54% | 18.17% | 15.73% |
| Stryker | 13.78% | 23.74% | 11.64% |
Insider and Institutional Ownership
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 0.6% of Intuitive Surgical shares are held by company insiders. Comparatively, 4.6% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for Intuitive Surgical and Stryker, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intuitive Surgical | 1 | 5 | 23 | 1 | 2.80 |
| Stryker | 0 | 7 | 21 | 0 | 2.75 |
Intuitive Surgical currently has a consensus price target of $495.90, suggesting a potential upside of 24.27%. Stryker has a consensus price target of $343.77, suggesting a potential upside of 10.93%. Given Intuitive Surgical’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Stryker.
Summary
Intuitive Surgical beats Stryker on 10 of the 15 factors compared between the two stocks.
About Intuitive Surgical
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
About Stryker
Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
